← 返回

香豆素在肿瘤免疫中的应用:从分子机制到治疗创新

英文原题:Coumarins in the tumor-immune application: from molecular mechanisms to therapeutic innovations.

查看英文原题

Coumarins in the tumor-immune application: from molecular mechanisms to therapeutic innovations.

PubMed 2025/10/09(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

香豆素类化合物是一类具有苯并-α-吡喃酮骨架的天然或合成分子。其取代基多样、生物学活性广泛,近年来在抗肿瘤治疗和免疫调节领域受到广泛关注。本文系统综述香豆素影响肿瘤免疫的机制。香豆素可通过诱导肿瘤细胞凋亡、抑制细胞增殖以及阻断上皮-间质转化(EMT)和血管生成,直接抑制肿瘤进展;也可调节血小板功能、巨噬细胞极化、T细胞活性、NK细胞细胞毒性及细胞因子网络,重塑肿瘤微环境(TME),从而增强宿主抗肿瘤免疫应答。尽管香豆素在肿瘤免疫治疗中潜力可观,其作用机制复杂,临床转化仍有限,安全性问题也有待进一步研究。本综述总结香豆素研究进展,讨论其开发面临的挑战和未来方向,旨在为香豆素在肿瘤免疫治疗中的机制分析和转化应用提供全面参考,并促进天然产物来源创新药物的开发和临床转化。

展开英文摘要原文

Coumarin compounds represent a class of natural or synthetic molecules characterized by a benzo- -pyrone skeleton. Their diverse substituents and extensive biological activities have garnered significant attention in the fields of anti-tumor therapy and immune regulation in recent years.

This article systematically reviews the mechanisms by which coumarins influence tumor immunity. Coumarins directly inhibit tumor progression by inducing apoptosis in tumor cells, inhibiting cellular proliferation, and blocking epithelial-mesenchymal transition (EMT) and angiogenesis.

However, they reshape the tumor microenvironment (TME) by regulating platelet function, macrophage polarization, T cell activity, NK cell cytotoxicity, and cytokine networks, thereby enhancing the host's anti-tumor immune response. Despite the promising potential of coumarins in tumor immunotherapy, their mechanisms are complex, their clinical translation remains limited, and safety concerns warrant further investigation.

This review summarizes the research progress on coumarins, discusses the challenges and future directions for their development, and aims to provide a comprehensive reference for the mechanism analysis and translational applications of coumarins in tumor immunotherapy.

Furthermore, it seeks to facilitate the development of innovative drugs derived from natural products and to promote their clinical translation.

论文信息

作者
Zhao Y、Jing L、Han L、Guo C、Yang Q
单位
Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, China.China
文献类型
综述
期刊
Frontiers in immunology2025
原文标识
PubMed 41142809 · DOI 10.3389/fimmu.2025.1681892